Cargando…
Mitochondria-targeted antioxidant therapy for an animal model of PCOS-IR
Polycystic ovary syndrome (PCOS) is a common endocrine disorder with unknown etiology and unsatisfactory clinical treatment. Considering the ethical limitations of studies involving humans, animal models that reflect features of PCOS and insulin resistance (IR) are crucial resources in investigating...
Autores principales: | Ding, Yu, Jiang, Zhaochang, Xia, Bohou, Zhang, Lizong, Zhang, Caijuan, Leng, Jianhang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257859/ https://www.ncbi.nlm.nih.gov/pubmed/30431108 http://dx.doi.org/10.3892/ijmm.2018.3977 |
Ejemplares similares
-
Potential Roles of mtDNA Mutations in PCOS-IR: A Review
por: Dong, Xiao-Chao, et al.
Publicado: (2023) -
The correlation between serum AMH and HOMA-IR among PCOS phenotypes
por: Wiweko, Budi, et al.
Publicado: (2018) -
Abstract 115: Lean PCOS and IR: A sine QUA non?
por: Misra, Sukirti
Publicado: (2022) -
Mitochondria-Targeted Antioxidants as Potential Therapy for the Treatment of Traumatic Brain Injury
por: Stelmashook, Elena V., et al.
Publicado: (2019) -
Association between HOMA-IR and ovarian sensitivity index in women with PCOS undergoing ART: A retrospective cohort study
por: Li, Yan, et al.
Publicado: (2023)